![Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis - ScienceDirect Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2468024920312857-fx1.jpg)
Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis - ScienceDirect
![The Symptoms and Impact of Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Conceptual Model of the Patient Experience | SpringerLink The Symptoms and Impact of Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Conceptual Model of the Patient Experience | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-019-01110-5/MediaObjects/12325_2019_1110_Fig1_HTML.png)
The Symptoms and Impact of Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Conceptual Model of the Patient Experience | SpringerLink
![Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire. | Semantic Scholar Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/212a6ead4554ea89c03122f205a78106d320af56/5-Table3-1.png)
Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire. | Semantic Scholar
![New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease | Clinical Proteomics | Full Text New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease | Clinical Proteomics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12014-020-09282-x/MediaObjects/12014_2020_9282_Fig1_HTML.png)
New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease | Clinical Proteomics | Full Text
![Focal Segmental Glomerulosclerosis Market 2021 Top 10 Global Players Introducing Future Opportunities and Demand by 2027 – GlaxoSmithKline plc., Novartis AG, AbbVie, Inc., Pfizer, Inc., Sanofi S.A | Medgadget Focal Segmental Glomerulosclerosis Market 2021 Top 10 Global Players Introducing Future Opportunities and Demand by 2027 – GlaxoSmithKline plc., Novartis AG, AbbVie, Inc., Pfizer, Inc., Sanofi S.A | Medgadget](https://www.medgadget.com/wp-content/uploads/2021/10/focal-segmental-glomerulosclerosis-market.jpg)
Focal Segmental Glomerulosclerosis Market 2021 Top 10 Global Players Introducing Future Opportunities and Demand by 2027 – GlaxoSmithKline plc., Novartis AG, AbbVie, Inc., Pfizer, Inc., Sanofi S.A | Medgadget
![Frontiers | Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association Frontiers | Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association](https://www.frontiersin.org/files/Articles/604961/fmed-07-604961-HTML-r1/image_m/fmed-07-604961-t001.jpg)
Frontiers | Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association
![Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors | Nefrología Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X2013251413052944:11871_16025_49155_en_t1_11871.jpg?idApp=UINPBA000064)
Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors | Nefrología
![Minimal change disease and idiopathic FSGS: manifestations of the same disease | Nature Reviews Nephrology Minimal change disease and idiopathic FSGS: manifestations of the same disease | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrneph.2016.147/MediaObjects/41581_2016_Article_BFnrneph2016147_Fig1_HTML.jpg)